<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2.2" -->
<rss version="0.92">
<channel>
	<title>My Alzheimers' Resource</title>
	<link>http://www.disease-alzheimers.com</link>
	<description>Information on alzheimer's disease</description>
	<lastBuildDate>Tue, 09 Mar 2010 05:03:58 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Has The Clock Struck 12 For Dimebon?</title>
		<description>The Cinderella story eventually has a happy ending, but to revelers in the Dimebon story right now the time must feel like five past midnight. Some scientists have considered the sudden transformation of a modest hay fever medicine from Russia into the latest star in the AD drug development arena ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/has-the-clock-struck-12-for-dimebon</link>
			</item>
	<item>
		<title>Technology And Positive Attitudes Improving Older People&#8217;s Lives</title>
		<description>The population of the UK is ageing. Sixteen per cent of the UK population is 65 or older, and for the first time, there are more people over the age of 65 than there are under the age of 18. This raises a lot of questions on issues such as ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/technology-and-positive-attitudes-improving-older-peoples-lives</link>
			</item>
	<item>
		<title>Major Depression More Than Doubles Risk Of Dementia Among Adults With Diabetes</title>
		<description>Adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only, according to a study published in the recent Journal of General Internal Medicine. Dementia is the progressive decline of thinking and reasoning abilities...

More:  continued here  </description>
		<link>http://www.disease-alzheimers.com/illness-diseases/major-depression-more-than-doubles-risk-of-dementia-among-adults-with-diabetes</link>
			</item>
	<item>
		<title>Alzforum&#8217;s 5-Part Series On Alzheimer&#8217;s Prevention Initiative</title>
		<description>The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute...

More: ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/alzforums-5-part-series-on-alzheimers-prevention-initiative</link>
			</item>
	<item>
		<title>Scientists Find New Form Of Prion Disease That Damages Brain Arteries</title>
		<description>WHAT: National Institutes of Health (NIH) scientists investigating how prion diseases destroy the brain have observed a new form of the disease in mice that does not cause the sponge-like brain deterioration typically seen in prion diseases. Instead, it resembles a form of human Alzheimer's disease, cerebral amyloid angiopathy, that ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/scientists-find-new-form-of-prion-disease-that-damages-brain-arteries</link>
			</item>
	<item>
		<title>New Prion Disease Damages Brain Arteries</title>
		<description> A team of scientists from the US and the UK have found a new type of prion disease in mice that damages brain arteries and may help us better  understand and treat types of Alzheimer's disease that cause similar damage. You can read a scientific paper about the ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/new-prion-disease-damages-brain-arteries</link>
			</item>
	<item>
		<title>Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine) Alzheimer&#8217;s Disease Clinical Development Program</title>
		<description>Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine*) in patients with Alzheimer's disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/pfizer-and-medivation-announce-results-from-two-phase-3-studies-in-dimebon-latrepirdine-alzheimers-disease-clinical-development-program</link>
			</item>
	<item>
		<title>Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer&#8217;s Treatment</title>
		<description>In an announcement today, Mount Sinai School of Medicine (MSSM) and Medisyn Technologies, Inc...

More:  continued here  </description>
		<link>http://www.disease-alzheimers.com/illness-diseases/mount-sinai-school-of-medicine-and-medisyn-technologies-discover-novel-compounds-for-alzheimers-treatment</link>
			</item>
	<item>
		<title>Testing The Ability Of Embedded Sensors To Detect Onset Of Dementia, Infirmity</title>
		<description>Carnegie Mellon University researchers in the Quality of Life Technology Center (QoLTC) will embed wireless sensors in the residences of about 50 older adults who live alone to see if they can detect subtle changes in everyday activities that indicate the onset of dementia or physical infirmities...

More:  continued here ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/testing-the-ability-of-embedded-sensors-to-detect-onset-of-dementia-infirmity</link>
			</item>
	<item>
		<title>Clues To The Role Of Brain Plaques Typical In Alzheimer&#8217;s Patients</title>
		<description>A study from EPFL's (Ecole Polytechnique Federale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of how Amyloid-Beta found in cerebral plaques, typically present in the brain of Alzheimer's ...</description>
		<link>http://www.disease-alzheimers.com/illness-diseases/clues-to-the-role-of-brain-plaques-typical-in-alzheimers-patients</link>
			</item>
</channel>
</rss>
